Navigation Links
Array BioPharma Announces Pricing Of Public Offering Of Common Stock
Date:11/9/2012

BOULDER, Colo., Nov. 9, 2012 /PRNewswire/ -- Array BioPharma Inc. (NasdaqGM: ARRY) announced today the pricing of an underwritten public offering of 18,000,000 primary shares of its common stock at a public offering price of $3.65 per share. The gross proceeds from the sale of the shares, before underwriting discounts and commissions and other offering expenses, are expected to be approximately $65.7 million. The offering is expected to close on or about November 15, 2012, subject to customary closing conditions. Array also granted the underwriters a 30-day option to purchase 2,700,000 additional shares of common stock to cover over-allotments, if any. All of the shares sold in the offering are being sold by Array, with the proceeds to be used to fund research and development activities and for general corporate purposes. Jefferies & Company, Inc. and J.P. Morgan Securities LLC are acting as joint book-running managers for the offering, with Piper Jaffray & Co., Stifel Nicolaus Weisel and William Blair acting as co-managers.

A shelf registration statement relating to the shares was filed with the Securities and Exchange Commission (the "SEC") and is effective. This press release does not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.  Any offer, if at all, will be made only by means of a prospectus, including a prospectus supplement, forming part of the effective shelf registration statement.

A preliminary prospectus supplement relating to the offering has been filed with the SEC and a final prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC's web site at www.sec.gov.  Copies of the final prospectus supplement and accompanying prospectus, when available, may be obt
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Array BioPharma Announces Proposed Public Offering Of Common Stock
2. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
3. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
4. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
5. Agility Clinical Expands Consulting Services to More Broadly Serve Small and Virtual Biopharma and Device Companies
6. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Third Quarter 2012 Financial Results
7. PDL BioPharma Announces Third Quarter 2012 Financial Results
8. PDL BioPharma to Announce Third Quarter 2012 Financial Results on November 5, 2012
9. New Study Highlights Enabling Factors for Biopharmaceutical Innovation in Middle-Income Countries
10. SAFC Enters South Korean BioPharma Market with CrystalGenomics Agreement
11. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 Hearing health affects a ... younger, and remain socially and professionally engaged, he should address ... overriding message that the Better Hearing Institute (BHI) ... National Men,s Health Week , which leads up to ... runs from June 10 through June 16. ...
(Date:5/23/2013)...  A recently published clinical study conducted at TOPS ... , demonstrates that 3D mammography (breast tomosynthesis) significantly reduces ... The study, "Implementation of Breast Tomosynthesis in a ... Stephen L. Rose , MD, and ... Journal of Roentgenology (AJR). The AJR is the ...
(Date:5/23/2013)... 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: ... based on intellectual property developed and owned by ... foremost medical research center, today announced that its ... funding from the Israeli Ministry of Industry and ... support product development and advance clinical trials. Cell ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... -- Phase II,results exceed expectations - Alchemia prepares ... company Alchemia Limited will,commence discussions with the US ... of the Phase II clinical trial,of its metastatic ... from the randomized Phase II clinical trial in ...
... data on Eloxatin(R), Taxotere(R) and on three investigational,agents ... at the 43rd,annual ASCO meeting, BRIDGEWATER, N.J., May ... total of 375 abstracts,indicative of its oncology commitment ... the American Society of Clinical Oncology,(ASCO) in Chicago, ...
Cached Medicine Technology:Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 2Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 3Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 4Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 2Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 4Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 5Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 6Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 7Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 8Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 9Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 10Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 11Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 12
(Date:5/24/2013)... 2013 BroadConnect Telecom, the nation’s ... and IT security solutions, present small to midsized ... by more than fifty percent (when compared to ... PBX Bundle Pricing. BroadConnect’s hosted Voice solutions are ... VoIP. , Starting today, until the end of ...
(Date:5/24/2013)... 24, 2013 With today’s levels of weight ... for advice on the causes of weight gain and how ... that suggest causes of weight gain and treatments that will ... was released by the Child Study Center at NYU ... childhood diagnosis of ADHD and the soring rates of obesity ...
(Date:5/24/2013)... Wednesday, 15th May 2013 | 10am BST | ... webinar playback: http://bit.ly/10Rt0ZH , Ongoing regulatory changes are ... the globe and particularly in Europe, a number of these ... . For dealmakers, understanding how the likes of Basel iii, ... your corner of the market will give you a competitive ...
(Date:5/24/2013)... IMED Mobility, a premier provider of wheelchair vans ... Michelle Murray on Thursday, June 20th 2 p.m to 5 p.m. ... and movie tour, which shares the story of Sam Schmidt, an ... in 2000. Much of the film takes place on the racetrack, ... INDYCAR racing despite suffering a crash that left him paralyzed. In ...
(Date:5/23/2013)... Sublime Beauty® is introducing its ... line, with a 35% discount through May 31st. ... proprietary products, the Cellulite Whisperer® Gel ... receive a report "Getting Control of Your Cellulite" ... wonderful grapefruit scent," says Kathy Heshelow, founder of ...
Breaking Medicine News(10 mins):Health News:BroadConnect Is Offering New Hosted PBX Bundle Pricing for New Customers, Eliminating VoIP Adoption Barriers 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Now Help Patients with Weight Gain Linked to Childhood ADHD Lose Weight Fast 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 3Health News:Local Mobility Dealer Hosts Nashville Recording Artist 2Health News:Fresh Organics in the New Cellulite Whisperer® Products from Sublime Beauty®; "Get Ready for Summer Sale" Continues 2
... WINNIPEG, June 30 /PRNewswire/ - Winnipeg-based medical device ... the 21st Century Achievement Award during the Computerworld ... in Washington D.C. IH Systems received the award ... Automation), the world,s first solution combining software, robotics ...
... 30 The Renal Physicians Association (RPA) supports Kidney ... in Kidney Care (PEAK) initiative. RPA is a member ... dialysis providers, physicians, manufacturers, and nurses who work together ... The goal of the PEAK campaign is to reduce ...
... that chronic disease in either a mother or father ... associated with the development of polycystic ovarian syndrome (PCOS) ... of women with PCOS and insulin resistance are themselves ... suggesting that factors associated with the condition can be ...
... have a diminished number of eggs in their ovaries, either ... as ovarian surgery, may be more at risk of a ... normal, fertile range. Trisomic pregnancies occur when the embryo ... two. The most common trisomy is Down,s syndrome or trisomy ...
... 2009 Elsevier, the leading publisher of scientific, technical ... publishing partnership with The European Association for the Study ... leading European association in the field of liver research. ... flagship journal, the Journal of Hepatology ( ...
... Calif., June 30 Endologix, Inc. (Nasdaq: ELGX ... announced that it has been added to the Russell 3000(R), ... after the close of the U.S. markets. , , ... Endologix is now included in the Russell Indexes, which has ...
Cached Medicine News:Health News:Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society 2Health News:Polycystic ovarian syndrome: New light on its causes and its effect on brothers 2Health News:Polycystic ovarian syndrome: New light on its causes and its effect on brothers 3Health News:Polycystic ovarian syndrome: New light on its causes and its effect on brothers 4Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 2Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 3Health News:Endologix Added to Russell Indexes 2
... Multifunctional instrumentation, capable of comminution, ... by means of ultra-sonic energy. ... organs, and, in particular, parenchymatous ... of tissue-selection and non-traumatic preparation ...
... system is the recognized world leader, ... superior tactile feedback and exceptional visualization ... surgical modality combines tissue fragmentation, irrigation, ... performance in procedures requiring precise, selective ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 7.5 mm....
Medicine Products: